3 US-Focused Drug Maker, Ethanol Chemical Firm and Milk Brand Stocks With a Strong Future Roadmap: Aurobindo Pharma, India Glycols and Heritage Foods

Aurobindo Pharma Rs 1,666.90, P/E 25.46. India Glycols Rs 331.95, P/E 7.58. Heritage Foods Rs 405.40, P/E 26.48. Closing prices of 14 Oct 2026.

Updated: 19 Oct 2026 • 2:27 pm

Posted by:

Quick Answer

US-focused drug maker, ethanol chemical firm and milk brand stocks with the clearest long-term roadmaps today include Aurobindo Pharma in generic formulations and active ingredients sold in the US, Europe and emerging markets, India Glycols in glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock and Heritage Foods in milk, curd and value-added dairy products sold across southern and other states. FY26 revenue growth was 5.6% at Aurobindo Pharma, 11.5% at India Glycols and 9.3% at Heritage Foods. P/E stands at 25.46 for Aurobindo Pharma (industry 37.59), 7.58 for India Glycols (industry 54.53) and 26.48 for Heritage Foods (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company's risks need equal attention.

US-focused drug maker, ethanol chemical firm and milk brand stocks give investors exposure to medicines, renewable-based chemicals and dairy products. Volumes, export demand and margins decide how much of that demand turns into profit.

This list covers three US-focused drug maker, ethanol chemical firm and milk brand stocks: Aurobindo Pharma for generic formulations and active ingredients sold in the US, Europe and emerging markets, India Glycols for glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock and Heritage Foods for milk, curd and value-added dairy products sold across southern and other states. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

Table of Contents

What Are Us-Focused Drug Maker, Ethanol Chemical Firm and Milk Brand Stocks?

US-focused drug maker, ethanol chemical firm and milk brand stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.

Us-Focused Drug Maker, Ethanol Chemical Firm and Milk Brand Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three US-focused drug maker, ethanol chemical firm and milk brand stocks as of the 14 Oct 2026 close.

Company	CMP (Rs)	Market Cap (Rs Cr)	P/E	Industry P/E	ROE	Debt to Equity
Aurobindo Pharma	1,666.90	94,477	25.46	37.59	9.25%	0.21
India Glycols	331.95	2,397	7.58	54.53	9.98%	0.58
Heritage Foods	405.40	3,562	26.48	34.85	13.61%	0.33

Among healthcare, chemicals and consumer stocks, all three trade at a discount to their industry P/E multiples.

Why Do Us-Focused Drug Maker, Ethanol Chemical Firm and Milk Brand Stocks Have a Strong Roadmap in India?

US-focused drug maker, ethanol chemical firm and milk brand stocks have a strong roadmap in India because generic drug demand overseas, ethanol and glycol use and packaged dairy sales keep adding volumes for these firms. Three drivers stand out.

Generic demand: Overseas markets buy affordable formulations and ingredients.
Renewable chemicals: Ethanol and glycols find wider industrial use.
Dairy demand: Households buy more curd and value-added dairy.

Aurobindo Pharma: Generic Formulations and Ingredients Build the Next Leg

Aurobindo Pharma's roadmap rests on generic formulations and active ingredients sold in the US, Europe and emerging markets, with a wide product basket supporting export revenue.

Revenue grew from Rs 23,775.84 crore in FY22 to Rs 34,145.17 crore in FY26, a 43.6% rise, and FY26 revenue was 5.6% higher than FY25. FY26 net profit rose 0.6% to Rs 3,502.97 crore. Over four years, net profit rose from Rs 2,647.11 crore in FY22 to Rs 3,502.97 crore. In Q1 FY27, revenue grew 18.1% to Rs 9,414.58 crore, and net profit rose 25.2% to Rs 1,032.03 crore. Operating margin was 21.61% in FY26 and 23.10% in Q1 FY27 against 21.95% a year earlier.

Debt to equity is 0.21 and return on equity is 9.25%. FY26 operating cash flow was Rs 5,526.37 crore against capital expenditure of Rs 3,104.67 crore. Aurobindo Pharma paid a dividend of Rs 4 per share for FY26, a yield of 0.25%. At a P/E of 25.46 against an industry P/E of 37.59, the stock trades below its industry multiple.

What to watch: Q1 FY27 operating margin was 23.10% against 21.61% for FY26, so margin stability is the figure to follow as volumes grow.

India Glycols: Green Chemicals and Ethanol Build the Next Leg

India Glycols' roadmap rests on glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock, with ethanol blending and chemical demand supporting volumes.

Revenue grew from Rs 2,889.84 crore in FY22 to Rs 4,216.34 crore in FY26, a 45.9% rise, and FY26 revenue was 11.5% higher than FY25. FY26 net profit rose 26.8% to Rs 292.76 crore. In Q1 FY27, revenue grew 19.3% to Rs 2,988.82 crore, and net profit rose 32.2% to Rs 96.83 crore. Operating margin was 7.12% in FY26.

Debt to equity is 0.58 and return on equity is 9.98%. FY26 operating cash flow was Rs 769.16 crore against capital expenditure of Rs 823.48 crore. India Glycols paid a dividend of Rs 7.5 per share for FY26, a yield of 2.10%. At a P/E of 7.58 against an industry P/E of 54.53, the stock trades below its industry multiple.

What to watch: The P/E of 7.58 against an industry P/E of 54.53 leaves valuation less stretched, so the next quarters' growth is the figure to follow.

Heritage Foods: Value-Added Dairy Drives the Pipeline

Heritage Foods' roadmap rests on milk, curd and value-added dairy products sold across southern and other states, with branded dairy demand supporting volumes.

Revenue grew from Rs 2,692.55 crore in FY22 to Rs 4,550.22 crore in FY26, a 69.0% rise, and FY26 revenue was 9.3% higher than FY25. FY26 net profit was Rs 150.14 crore. In Q1 FY27, revenue grew 17.7% to Rs 1,344.50 crore. Operating margin was 5.86% in FY26.

Debt to equity is 0.33 and return on equity is 13.61%. FY26 operating cash flow was Rs 237.18 crore against capital expenditure of Rs 382.39 crore. Heritage Foods paid a dividend of Rs 2.5 per share for FY26, a yield of 0.65%. At a P/E of 26.48 against an industry P/E of 34.85, the stock trades below its industry multiple.

What to watch: Net profit margin is only 3.3%, so small cost changes move earnings.

Best Us-Focused Drug Maker, Ethanol Chemical Firm and Milk Brand Stocks in India: Aurobindo Pharma vs India Glycols vs Heritage Foods on Key Financials

Among the best US-focused drug maker, ethanol chemical firm and milk brand stocks in India, Aurobindo Pharma leads on FY26 operating margin and the lowest debt to equity; India Glycols leads on FY26 revenue growth and Q1 FY27 revenue growth; Heritage Foods leads on return on equity. The table puts the numbers side by side.

Metric	Aurobindo Pharma	India Glycols	Heritage Foods
FY26 revenue (Rs Cr)	34,145.17	4,216.34	4,550.22
FY26 revenue growth	5.6%	11.5%	9.3%
FY26 net profit (Rs Cr)	3,502.97	292.76	150.14
FY26 operating profit margin	21.61%	7.12%	5.86%
Q1 FY27 revenue growth (YoY)	18.1%	19.3%	17.7%
Return on equity	9.25%	9.98%	13.61%
P/E ratio	25.46	7.58	26.48
Debt to equity	0.21	0.58	0.33
Dividend yield	0.25%	2.10%	0.65%
FY26 operating cash flow (Rs Cr)	5,526.37	769.16	237.18

Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Us-Focused Drug Maker, Ethanol Chemical Firm and Milk Brand Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen US-focused drug maker, ethanol chemical firm and milk brand stocks and shortlist US-focused drug maker, ethanol chemical firm and milk brand stocks to buy.

Compare each stock's P/E with its industry P/E, which differs by company here.
Check revenue growth, operating margin and cash flow together.
Check whether revenue growth is turning into profit growth, not only sales.
Read operating cash flow against capital expenditure to see how growth is funded.
Watch debt to equity and interest cover before sizing a position.
Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these US-focused drug maker, ethanol chemical firm and milk brand stocks

Risks to Consider Before Investing in Us-Focused Drug Maker, Ethanol Chemical Firm and Milk Brand Stocks

Consumer demand: Spending patterns can shift sales between quarters.
Input costs: Changes in raw material prices can affect margins.
Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track Aurobindo Pharma, India Glycols and Heritage Foods live.

Final Take: Which Stock Has the Strongest Roadmap?

These three healthcare, chemicals and consumer stocks cover generics, glycols and dairy. Aurobindo Pharma leads on FY26 operating margin and the lowest debt to equity; India Glycols leads on FY26 revenue growth and Q1 FY27 revenue growth; Heritage Foods leads on return on equity.

Across US-focused drug maker, ethanol chemical firm and milk brand stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the US-focused drug maker, ethanol chemical firm and milk brand stocks to buy discussed here.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Us-Focused Drug Maker, Ethanol Chemical Firm and Milk Brand Stocks

Which are the best US-focused drug maker, ethanol chemical firm and milk brand stocks in India with a strong roadmap?

Ans. Aurobindo Pharma, India Glycols and Heritage Foods stand out for their roadmaps in generics, glycols and dairy. FY26 revenue growth was 5.6% at Aurobindo Pharma, 11.5% at India Glycols and 9.3% at Heritage Foods, and return on equity ranges from 9.25% to 13.61%.

Is Aurobindo Pharma a good stock to buy now?

Ans. Aurobindo Pharma has a debt to equity ratio of 0.21, a return on equity of 9.25% and a P/E of 25.46 against an industry P/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of Aurobindo Pharma, India Glycols and Heritage Foods?

Ans. The P/E ratio is 25.46 for Aurobindo Pharma (industry 37.59), 7.58 for India Glycols (industry 54.53) and 26.48 for Heritage Foods (industry 34.85). All of them trade below the industry multiple.

Which of these US-focused drug maker, ethanol chemical firm and milk brand stocks has the highest return on equity?

Ans. Heritage Foods has the highest return on equity at 13.61%, followed by India Glycols at 9.98% and Aurobindo Pharma at 9.25%.

What are the risks of investing in US-focused drug maker, ethanol chemical firm and milk brand stocks?

Ans. The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.

How did Aurobindo Pharma, India Glycols and Heritage Foods perform in Q1 FY27?

Ans. Aurobindo Pharma reported revenue of Rs 9,414.58 crore, up 18.1% year on year, and net profit rose 25.2% to Rs 1,032.03 crore. India Glycols reported revenue of Rs 2,988.82 crore, up 19.3% year on year, and net profit rose 32.2% to Rs 96.83 crore. Heritage Foods reported revenue of Rs 1,344.50 crore, up 17.7% year on year.

Do US-focused drug maker, ethanol chemical firm and milk brand stocks pay dividends?

Ans. Yes, all three companies pay dividends. The dividend yield is 0.25% for Aurobindo Pharma, 2.10% for India Glycols and 0.65% for Heritage Foods, based on dividends declared for FY26.

How can I invest in US-focused drug maker, ethanol chemical firm and milk brand stocks in India?

Ans. You can buy US-focused drug maker, ethanol chemical firm and milk brand stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.